新西兰研究人员开发人工智能植入器,以适应性方式实时管理心脏状况。 New Zealand researchers develop AI-powered implants that adaptively manage heart conditions in real time.

奥克兰大学研究人员认为,AI驱动的医疗设备可以通过动态调节心率、血压和实时节奏,改变心脏病治疗。 AI-powered medical devices could transform heart disease treatment by dynamically regulating heart rate, blood pressure, and rhythm in real time, according to University of Auckland researchers. 这些生物电子植入物可以学习个人生理形态,其目的是对偏差(如高血压)自动作出反应,这些偏差是相对于目前静态装置的重大进步。 These bioelectronic implants, which learn individual physiological patterns, aim to respond automatically to deviations—like high blood pressure—offering a major advancement over current static devices. 大学的多学科团队正在开发这一技术,该技术可以与干细胞疗法相结合,修复受损的神经。 The university’s multidisciplinary team is developing the technology, which may combine with stem cell therapies to repair damaged nerves. 虽然在数据安全、维护和公众信任方面仍然存在挑战,但专家说,投资是将研究转化为市场准备就绪的解决办法的关键,使新西兰成为日益增长的全球生物技术产业的领先者。 While challenges remain in data security, maintenance, and public trust, experts say investment is key to turning research into market-ready solutions, positioning New Zealand as a leader in a growing global medtech industry.